Studio Del Rosso & Associati successfully facilitated the divestment of Biogamma S.r.l., enhancing the consolidation trend in the Campanian healthcare sector.
Overview of Biogamma S.r.l.
Biogamma S.r.l., a laboratory specializing in clinical analysis, has successfully completed a significant divestment. This operation was supported by Studio Del Rosso & Associati, which acted as the advisor throughout the transaction. The involvement of the firm included several strategic phases aimed at ensuring a smooth transfer of ownership while maximizing the financial benefits for the sellers.
The advisory services of Studio Del Rosso & Associati encompassed identifying qualified investors, conducting comprehensive due diligence, and developing contractual agreements. This meticulous approach not only ensured accurate valuation of the company but also facilitated favorable tax conditions for the shareholders involved in the sale.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Campania
The clinical analysis laboratory sector in Campania is currently undergoing significant transformation marked by increasing consolidation. Rising capital expenditures, organizational costs, and regional spending limits hav
Similar Deals
Novartis AG → Avidity Biosciences, Inc.
2026
Not specified
invested in
Laboratorio Biogamma S.r.l.
in
in a Merger deal